Can Clomipramine Cause Hypertension?
Yes, clomipramine can cause hypertension, particularly in patients with tumors of the adrenal medulla (pheochromocytoma, neuroblastoma), where it may provoke hypertensive crises. However, the more common cardiovascular effect is orthostatic hypotension rather than sustained hypertension.
Primary Cardiovascular Effects
The FDA drug label explicitly warns that clomipramine should be used with caution in patients with tumors of the adrenal medulla (e.g., pheochromocytoma, neuroblastoma) in whom the drug may provoke hypertensive crises 1. This represents the most clinically significant hypertensive risk.
More Common: Orthostatic Hypotension
The predominant blood pressure effect of clomipramine is orthostatic hypotension, not hypertension. Multiple controlled studies demonstrate:
- Clomipramine causes statistically significant falls in both systolic and diastolic orthostatic blood pressure 2, 3
- In a randomized trial of 115 depressed patients, clomipramine (150 mg/day) produced significant orthostatic drops in systolic (F = 9.37, P = 0.0037) and diastolic blood pressure (F = 3.74, P = 0.0017), while moclobemide did not 2
- The orthostatic effect shows a curvilinear correlation with plasma levels, most pronounced at 1-2 weeks with plasma levels of 25-75 mcg/L 3
- Older patients (56-70 years) experience more severe orthostatic hypotension than younger patients 4
Paradoxical Tachycardia
While blood pressure typically drops with position changes, modest tachycardia occurs in approximately 20% of patients taking clomipramine 1. Research shows that heart rate actually increases during clomipramine treatment (while it decreases with placebo), despite the orthostatic blood pressure drops 5.
Clinical Context: Antidepressants and Blood Pressure
Among antidepressants, tricyclic antidepressants like clomipramine are more commonly associated with orthostatic hypotension than sustained hypertension 6. The 2020 ISH guidelines specifically note that beta-blockers (not metoprolol) should be used in the presence of drug-induced tachycardia from antidepressant or antipsychotic drugs 7.
Key Clinical Caveats
Screen for pheochromocytoma: Before prescribing clomipramine, evaluate for adrenal medullary tumors if there's any clinical suspicion, as this represents the primary hypertensive risk 1
Monitor orthostatic vital signs: The FDA label notes that approximately 20% of patients experience modest orthostatic blood pressure decreases, though patients are frequently asymptomatic 1
Age matters: Patients over 56 years require closer monitoring for orthostatic effects 4
Cardiovascular disease: Use caution in patients with known cardiovascular disease, with gradual dose titration recommended 1
ECG monitoring: Among 1400 patients in premarketing studies, 1.5% developed ECG abnormalities (PVCs, ST-T wave changes, intravenous conduction abnormalities), though rarely clinically significant 1
Bottom Line
Clomipramine is far more likely to cause orthostatic hypotension than sustained hypertension in most patients. The exception is patients with pheochromocytoma or neuroblastoma, where hypertensive crises can occur. Monitor blood pressure both supine and standing, particularly in elderly patients and those with cardiovascular disease.